Risk-Stratified Treatment in Chronic Lymphocytic Leukemia

por Stephens, Deborah M., Goodrich, Amy L.
Publicado 2016

Secondary malignancies in non‐Hodgkin lymphoma survivors: 40 years of follow‐up assessed by treatment modality

por Parsons, Matthew W., Rock, Calvin, Chipman, Jonathan J., Shah, Harsh R., Hu, Boyu, Stephens, Deborah M., Tao, Randa, Tward, Jonathan D., Gaffney, David K.
Publicado 2022

Association of rituximab with graphene oxide confers direct cytotoxicity for CD20-positive lymphoma cells

por Luo, Chengke, Deng, Zhenghao, Li, Lan, Clayton, Frederic, Chen, Alexander L., Wei, Ran, Miles, Rodney, Stephens, Deborah M., Glenn, Martha, Wang, Xiyang, Jensen, Peter E., Chen, Xinjian
Publicado 2016

Shared genomic segment analysis in a large high-risk chronic lymphocytic leukemia pedigree implicates CXCR4 in inherited risk

por Feusier, Julie E., Madsen, Michael J., Avery, Brian J., Williams, Justin A., Stephens, Deborah M., Hu, Boyu, Osman, Afaf E. G., Glenn, Martha J., Camp, Nicola J.
Publicado 2021

Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001

por Stephens, Deborah M., Li, Hongli, Constine, Louis S., Fitzgerald, Thomas J., Leonard, John P., Kahl, Brad S., Song, Joo Y., LeBlanc, Michael L., Smith, Sonali M., Persky, Daniel O., Friedberg, Jonathan W.
Publicado 2022

Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy

por Rock, Calvin B., Chipman, Jonathan J., Parsons, Matthew W., Weil, Chris R., Hutten, Ryan J., Tao, Randa, Tward, Jonathan D., Shah, Harsh R., Hu, Boyu, Stephens, Deborah M., Gaffney, David K.
Publicado 2022

Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL

por Siddiqi, Tanya, Soumerai, Jacob D., Dorritie, Kathleen A., Stephens, Deborah M., Riedell, Peter A., Arnason, Jon, Kipps, Thomas J., Gillenwater, Heidi H., Gong, Lucy, Yang, Lin, Ogasawara, Ken, Thorpe, Jerill, Wierda, William G.
Publicado 2022

The COVID-19 Pandemic and In-Person Visit Rate Disruptions Among Patients With Hematologic Neoplasms in the US in 2020 to 2021

por Goyal, Gaurav, Lau, Krystal W., Wang, Xiaoliang, Davidoff, Amy J., Huntington, Scott F., Jamy, Omer, Calip, Gregory, Shah, Harsh, Stephens, Deborah M., Miksad, Rebecca, Parikh, Ravi B., Takvorian, Samuel, Neparidze, Natalia, Seymour, Erlene K.
Publicado 2023

Impact of Targeted Therapy on Outcome of Chronic Lymphocytic Leukemia Patients with Relapsed Del(17p13.1) Karyotype at a Single Center

por Stephens, Deborah M., Ruppert, Amy S., Jones, Jeffrey, Woyach, Jennifer, Maddocks, Kami, Jaglowski, Samantha, Andritsos, Leslie A., Flynn, Joseph M., Grever, Michael R., Lozanski, Gerard, Johnson, Amy J., Muthusamy, Natarajan, Heerema, Nyla A., Byrd, John C.
Publicado 2014

Racial Disparities in Telemedicine Uptake during the COVID-19 Pandemic Among Patients with Hematologic Malignancies in the United States

por Neparidze, Natalia, Lau, Krystal W., Wang, Xiaoliang, Davidoff, Amy J., Huntington, Scott F., Jamy, Omer Hassan, Calip, Gregory, Shah, Harsh, Stephens, Deborah M., Miksad, Rebecca A., Parikh, Ravi, Takvorian, Samuel, Goyal, Gaurav, Seymour, Erlene K
Publicado 2021

Impact of the COVID-19 Pandemic on in-Person Visit Rates Among Patients with Hematologic Malignancies in the United States

por Goyal, Gaurav, Lau, Krystal W., Wang, Xiaoliang, Davidoff, Amy J., Huntington, Scott F., Jamy, Omer Hassan, Calip, Gregory, Shah, Harsh, Stephens, Deborah M., Miksad, Rebecca A., Parikh, Ravi, Takvorian, Samuel, Neparidze, Natalia, Seymour, Erlene K
Publicado 2021

Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients

por Brown, Jennifer R., Byrd, John C., Ghia, Paolo, Sharman, Jeff P., Hillmen, Peter, Stephens, Deborah M., Sun, Clare, Jurczak, Wojciech, Pagel, John M., Ferrajoli, Alessandra, Patel, Priti, Tao, Lin, Kuptsova-Clarkson, Nataliya, Moslehi, Javid, Furman, Richard R.
Publicado 2021

P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patie...

por Viviani, Simonetta, Pavoni, Chiara, Barrington, Sally F., Guerra, Luca, Schöder, Heiko, Johnson, Peter, Kirkwood, Amy A., Stephens, Deborah M., Friedberg, Jonathan W., Chauvie, Stephane, Knopp, Michael V., Federico, Massimo, Enblad, Gunilla, Corradini, Paolo, Gallamini, Andrea, Rambaldi, Alessandro, Tarella, Corrado
Publicado 2022

Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration

por Stephens, Deborah M., Boucher, Ken, Kander, Elizabeth, Parikh, Sameer A., Parry, Erin M., Shadman, Mazyar, Pagel, John M., Cooperrider, Jennifer, Rhodes, Joanna, Mato, Anthony, Winter, Allison, Hill, Brian, Gaballa, Sameh, Danilov, Alexey, Phillips, Tycel, Brander, Danielle M., Smith, Sonali M., Davids, Matthew S., Rogers, Kerry, Glenn, Martha J., Byrd, John C.
Publicado 2020

P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma

por Shah, Harsh, Vardell, Victoria, Zacholski, Erin, Fegley, Amanda, Fedak, Kalub, Sundaram, Suchitra, Rajeeve, Sridevi, Goyal, Gaurav, Hatic, Haris, Torka, Pallawi, Ba Aqeel, Sheeba, Borogovac, Azra, Macdougall, Kira, Kothari, Shalin, Kress, Anna, Modi, Dipenkumar, Travers, Elizabeth, Chilakamarri, Nitin, Brem, Elizabeth, Stephens, Deborah M., Hu, Boyu, Fitzgerlad, Lindsey, Wagner, Charlotte, Ermann, Daniel
Publicado 2022

A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma

por Shouse, Geoffrey, Kaempf, Andy, Gordon, Max J., Artz, Andy, Yashar, David, Sigmund, Audrey M., Smilnak, Gordon, Bair, Steven M., Mian, Agrima, Fitzgerald, Lindsey A., Bajwa, Amneet, Jaglowski, Samantha, Bailey, Neil, Shadman, Mazyar, Patel, Krish, Stephens, Deborah M., Kamdar, Manali, Hill, Brian T., Gauthier, Jordan, Karmali, Reem, Nastoupil, Loretta J., Kittai, Adam S., Danilov, Alexey V.
Publicado 2023

Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia

por Ujjani, Chaitra, Gooley, Ted A., Spurgeon, Stephen E., Stephens, Deborah M., Lai, Catherine, Broome, Catherine M., O’Brien, Susan, Zhu, Haiying, Laing, Kerry J., Winter, Allison M., Pongas, Georgios, Greninger, Alexander L, Koelle, David M., Siddiqi, Tanya, Davids, Matthew S., Rogers, Kerry A., Danilov, Alexey V., Sperling, Amy, Tu, Brian, Sorensen, Tyler, Launchbury, Kelsey, Burrow, Carlissa J., Quezada, Genesis, Hill, Joshua A., Shadman, Mazyar, Thompson, Philip A.
Publicado 2022

Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outc...

por Wagner, Charlotte B., Boucher, Ken, Nedved, Adrienne, Micallef, Ivana N., Desai, Sanjal, Hatic, Haris, Goyal, Gaurav, Zacholski, Erin, Fegley, Amanda, Sigmund, Audrey M., Bond, David A., Samuels, Courtney, Kamdar, Manali K., Aqeel, Sheeba Ba, Torka, Pallawi, MacDougall, Kira, Borogovac, Azra, Rajeeve, Sridevi, Sundaram, Suchitra, Fedak, Kalub, Modi, Dipenkumar, Travers, Elizabeth, Ayyappan, Sabarish, Chilakamarri, Nitin, Brem, Elizabeth A., Ermann, Daniel A., Fitzgerald, Lindsey A., Hu, Boyu, Stephens, Deborah M., Shah, Harsh
Publicado 2023

Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study

por Epperla, Narendranath, Feng, Lei, Shah, Nirav N., Fitzgerald, Lindsey, Shah, Harsh, Stephens, Deborah M., Lee, Catherine J., Ollila, Thomas, Shouse, Geoffrey, Danilov, Alexey V., David, Kevin A., Torka, Pallawi, Hashmi, Hamza, Hess, Brian, Barta, Stefan K., Romancik, Jason T., Cohen, Jonathon B., Annunzio, Kaitlin, Kittai, Adam S., Reneau, John, Zurko, Joanna, Nizamuddin, Imran A., Winter, Jane N., Gordon, Leo I., Ma, Shuo, Patel, Romil, Nastoupil, Loretta, Ahmed, Sairah, Karmali, Reem
Publicado 2023

Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions

por Major, Ajay, Yu, Jovian, Shukla, Navika, Che, Yan, Karrison, Theodore G., Treitman, Rachel, Kamdar, Manali K., Haverkos, Bradley M., Godfrey, James, Babcook, Melissa A., Voorhees, Timothy J., Carlson, Sophie, Gaut, Daria, Oliai, Caspian, Romancik, Jason T., Winter, Allison M., Hill, Brian T., Bansal, Radhika, Villasboas Bisneto, Jose C., Nizamuddin, Imran A., Karmali, Reem, Fitzgerald, Lindsey A., Stephens, Deborah M., Pophali, Priyanka A., Trabolsi, Asaad, Schatz, Jonathan H., Hu, Marie, Bachanova, Veronika, Slade, Michael J., Singh, Nathan, Ahmed, Nausheen, McGuirk, Joseph P., Bishop, Michael R., Riedell, Peter A., Kline, Justin
Publicado 2023